Study notes nursing hen providing care for a pregnant woman, the nurse should be aware tha, Study notes of Medicine

Study guides to help you with meds urge class. study notes. The most frequently reported maternal medical risk factors are diabetes and hypertension associated with pregnancy. Both of these conditions are associated with maternal obesity. There are no studies that indicate MVP is among the most frequently reported maternal risk factors. Hypertension associated with pregnancy, not chronic hypertension, is one of the most frequently reported maternal medical risk factors. Although anemia is a concern in pregnancy, it is not one of the most frequently reported maternal medical risk factors in pregnancy.

Typology: Study notes

2025/2026

Uploaded on 01/30/2026

arrrrrri
arrrrrri 🇺🇸

3 documents

1 / 17

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
I. Upper Respiratory Tract
Structures: Nose, mouth, pharynx (nasopharynx, oropharynx, laryngopharynx), epiglottis,
larynx, trachea
Functions:
oNose: warms, humidifies, filters air; contains turbinates; olfactory nerve (smell)
The inside of the nose is shaped into 3 passages by projections called
turbinates.
The turbinates increase the surface area of the nasal mucosa that warms and
moistens the air as it enters the nose.
oPharynx: Subdivided into 3 parts: nasopharynx, oropharynx, and laryngopharynx.
Air moves through the oropharynx to the laryngopharynx. It then travels
through the epiglottis to the larynx before moving into the trachea.
oEpiglottis: prevents aspiration during swallowing
oLarynx: vocal cords, glottis (opening between cords)
oTrachea: U-Shaped cartilages keep the trachea open but allow the adjacent esophagus
to expand for swallowing, divides at carina → right/left main bronchi
5 inches (10 to 12 cm) long and 1 inch (1.5 to 2.5 cm) in diameter
oCarina: highly sensitive, stimulation → vigorous cough
II. Lower Respiratory Tract
Once air passes the carina, it is in the lower respiratory tract
Structures: bronchi, bronchioles, alveolar ducts, alveoli
Lungs:
oRight lung: 3 lobes
oLeft lung: 2 lobes
Hilus: entry point for bronchi, vessels, nerves
Bronchi branching: lobar → segmental → subsegmental → bronchioles
oThe right mainstem bronchus is shorter, wider, and straighter than the left mainstem
bronchus. That is why aspiration is more likely to occur in the right lung than in the left
lung.
Bronchoconstriction vs. bronchodilation: airway diameter controlled by smooth muscle
Dead space (VD): ~150 mL of 500 mL tidal volume → no gas exchange
oThe volume of air in the trachea and bronchi
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff

Partial preview of the text

Download Study notes nursing hen providing care for a pregnant woman, the nurse should be aware tha and more Study notes Medicine in PDF only on Docsity!

I. Upper Respiratory Tract

 Structures: Nose, mouth, pharynx (nasopharynx, oropharynx, laryngopharynx), epiglottis,

larynx, trachea

 Functions:

o Nose: warms, humidifies, filters air; contains turbinates; olfactory nerve (smell)

 The inside of the nose is shaped into 3 passages by projections called

turbinates.

 The turbinates increase the surface area of the nasal mucosa that warms and

moistens the air as it enters the nose.

o Pharynx: Subdivided into 3 parts: nasopharynx, oropharynx, and laryngopharynx.

 Air moves through the oropharynx to the laryngopharynx. It then travels

through the epiglottis to the larynx before moving into the trachea.

o Epiglottis: prevents aspiration during swallowing

o Larynx: vocal cords, glottis (opening between cords)

o Trachea: U-Shaped cartilages keep the trachea open but allow the adjacent esophagus

to expand for swallowing, divides at carina → right/left main bronchi

 5 inches (10 to 12 cm) long and 1 inch (1.5 to 2.5 cm) in diameter

o Carina: highly sensitive, stimulation → vigorous cough

II. Lower Respiratory Tract

 Once air passes the carina, it is in the lower respiratory tract

 Structures: bronchi, bronchioles, alveolar ducts, alveoli

 Lungs:

o Right lung: 3 lobes

o Left lung: 2 lobes

 Hilus: entry point for bronchi, vessels, nerves

 Bronchi branching: lobar → segmental → subsegmental → bronchioles

o The right mainstem bronchus is shorter, wider, and straighter than the left mainstem

bronchus. That is why aspiration is more likely to occur in the right lung than in the left lung.

 Bronchoconstriction vs. bronchodilation: airway diameter controlled by smooth muscle

 Dead space (VD): ~150 mL of 500 mL tidal volume → no gas exchange

o The volume of air in the trachea and bronchi

 Alveoli: ~300 million; interconnected by pores of Kohn (allow movement of air from alveolus to

alveolus); volume ~2500 mL; surface area = tennis court

o Primary site of gas exchange for O2 and CO

o Bacteria can move through pores of Kohn, spreading infection to previously uninfected

areas

 Gas exchange: across alveolar–capillary membrane; impaired by pulmonary edema (excess

fluid fills the interstitial space and alveoli reducing gas exchange) III. Surfactant & Atelectasis

 Surfactant: lipoprotein reducing alveolar surface tension, prevents collapse

o Reduces the amount of pressure needed to inflate the alveoli and makes them less

likely to collapse

o Sighing every 5 to 6 breaths stretches the alveoli and promotes surfactant secretion

 Atelectasis: collapsed alveoli due to lack of surfactant

o Postoperative patient: At risk for atelectasis due to effects of anesthesia, decreased

mobility, and pain, which can alter breathing and lung expansion

 Acute respiratory distress syndrome (ARDs): Lack of surfactant contributes to widespread

atelectasis and collapse of lung tissue IV. Blood Supply

 Pulmonary circulation: right ventricle → pulmonary arteries (deoxygenated blood) → alveoli

(gas exchange) → pulmonary veins (oxygenated blood) → left atrium → left ventricle → systemic circulation

o Provides the lungs with blood that take part in gas exchange

o Venous blood is collected from capillary networks of the body and returned to the right

atrium by way of the superior and inferior vena cava.

 Bronchial circulation: Does not take part in gas exchange but provides O2 to the bronchi and

other lung tissues, deoxygenated blood returns via azygos vein into the superior vena cava

o Starts with bronchial arteries

V. Chest Wall & Pleura

 Shaped, supported, and protected by 24 ribs

 Thoracic cage: ribs, sternum, mediastinum (separates lungs)

o Protects the lungs and heart from injury

Inspiration : active process; diaphragm contracts, external intercostals expand chest; negative intrathoracic pressure pulls air in  Expiration : normally passive (elastic recoil); active when forced (abdominal & internal intercostal muscles). Return to their original size after being stretched or expanded. When intrathoracic pressure rises air moves out of the lungs.  COPD/asthma : expiration becomes active due to airflow obstruction  When dyspnea (shortness of breath) occurs, neck and shoulder muscles, and other accessory muscles of respiration, can aid the effort

  1. Compliance & Resistance

 Compliance: Ease of lung expansion. The ability of the lungs to expand

o ↓ compliance (harder for lungs to inflate):

 Conditions that increase fluids: Pulmonary edema, ARDs, pneumonia)

 Conditions that make tissue less elastic: Pulmonary fibrosis, sarcoidosis

 Conditions that restrict lung movements: Pleural effusion

o ↑ compliance: COPD (destruction of alveolar walls and loss of tissue elasticity)

 Resistance: Any obstacle to airflow during inspiration and/or expiration. Airway diameter

decreases with asthma which increases resistance (treated with bronchodilators). Secretion exclude the airway increases resistance (treated with mucolytics or expectorants)

  1. Control of Respiration

 Brainstem (medulla): primary control

 Chemoreceptors:

o Receptors that respond to chemical composition changes (PaCO₂, pH)

 Central Chemoreceptors

o Location: Medulla.

o Stimulus: Changes in hydrogen ion (H⁺) concentration (via PaCO₂ and cerebrospinal

fluid pH).

o Response:

 ↑ H⁺ (acidosis) → medulla increases respiratory rate & tidal volume (VT).

 ↓ H⁺ (alkalosis) → opposite effect (slows respiration).

o Mechanism: CO₂ + H₂O → H₂CO₃ → dissociates to H⁺ → lowers CSF pH → stimulates

breathing.

 Peripheral chemoreceptors

o Location: Carotid bodies (at bifurcation of common carotid arteries). Aortic bodies

(above & below aortic arch).

o Stimulus:

 ↓ PaO₂

 ↓ pH

 ↑ PaCO₂

o Response: Stimulate respiratory center to increase ventilation.

 COPD consideration:

o COPD = chronically elevated PaCO₂.

o Central chemoreceptors become less sensitive to CO₂.

o Ventilation maintained mainly by hypoxic drive (peripheral chemoreceptors

responding to low PaO₂).

 Mechanical receptors:

o Irritant receptors:

 Found in conducting airways.

 Sensitive to inhaled particles/aerosols.

 Trigger cough reflex.

o Stretch receptors:

 Located in smooth muscle of airways.

 Control respiration by preventing overinflation.

 Responsible for Hering-Breuer reflex → inhibits inspiration as lungs inflate.

o Juxtacapillary (J) receptors:

 Found in alveolar capillaries.

 Stimulated by ↑ pulmonary capillary pressure.

 Cause rapid, shallow breathing (tachypnea) , e.g., in pulmonary edema.

VII. Respiratory Defense Mechanisms

 Air filtration: nasal hairs, increased air turbulence (due to abrupt changes in direction of airflow

that occur as air moves through the nasopharynx and larynx)

o Most large particles (greater than 5 μm) are less dangerous because they are removed

in the nasopharynx or bronchi and do not reach the alveoli

 Mucociliary clearance: 100 mL mucus/day

o Also called the mucociliary escalator, responsible for the movement of mucus

o Secretory immunoglobulin A (IgA) in the mucus helps protect against bacteria and

viruses

o Dehydration, smoking, inhaling high O2 concentrations, infection, and drugs, such as

atropine, anesthetics, alcohol, or cocaine, impair ciliary action

IX. Assessment of Respiratory System A. Subjective Data

 History: upper/lower respiratory issues, allergies, family history (Box 27.1 Genetic Risk Alert:

CF, α1-antitrypsin deficiency, asthma, COPD risk)

o Ask about asthma, COPD, pneumonia, and TB

o Ask the patient with allergies about possible precipitating factors or triggers, such as

medications, pollen, smoke, mold, or pet exposure

 Medications: inhalers, ACE inhibitors (cough), O2 therapy

o Ask about the dose (if known), frequency, length of time taken, side effects, and the

reason for taking the medication

o Cough is a common side effect of angiotensin-converting enzyme (ACE) inhibitors

o Include the patient’s cognitive and physical ability related to using O2 and any

metered-dose inhalers.

 Surgeries/treatments: intubation, chest physiotherapy

o Determine if the patient has ever been intubated because of a respiratory problem.

1. Change in Health Status

 Ask about perceived changes over days, months, or years.

 COPD: lung function declines slowly; patients may not notice due to activity modification.

 Acute changes (e.g., infection): sudden dyspnea, decreased exercise tolerance.

 Asthma: symptoms may worsen with exercise, mold, temperature changes, or pollution.

2. Course of Illness

 Determine onset, type of symptoms, and aggravating/relieving factors.

 Patients with chronic disease often report changes in existing symptoms (not new ones).

 Example: Increased SOB or purulent sputum may suggest acute COPD exacerbation.

3. Cough Assessment

 Identify quality:

o Loose = secretions

o Dry/hacking = airway irritation/obstruction

o Harsh/barky = upper airway obstruction (e.g., subglottic edema)

 Assess strength of cough (can secretions be cleared?).

 Productive vs. nonproductive.

 Acute vs. chronic (chronic = >3 weeks).

 Ask about cough pattern: regular, paroxysmal, time-related, activity-related, weather-related,

triggers (talking, deep breathing).

 Identify relief measures tried (Rx or OTC).

4. Sputum Characteristics (if productive cough)

 Evaluate: amount, color, consistency, odor.

 Quantify daily volume; note changes.

 Normal: clear/whitish.

 Smokers: clear to gray, sometimes brown specks.

 COPD: whitish/yellow, especially in morning.

 Concerning changes:

o Color change → possible complications.

o Consistency: thick, thin, frothy, pink-tinged (possible pulmonary edema).

o Odor: foul = infection.

 Ask if sputum varies with position (↑ lying down) or activity.

5. Hemoptysis (blood in sputum)

 Ranges: streaks → massive bleeding.

 Differentiate from hematemesis (vomiting blood).

 Causes: pneumonia, TB, lung cancer, severe bronchiectasis.

 Dyspnea scale: Modified Borg Scale (0–10)

1. Breathing & Airway History

 Ask about history of breathing difficulties.

 Wheezing = airway obstruction (asthma, foreign body, emphysema).

 Family exposure to TB.

2. Smoking & Environmental Exposure

 Smoking = most important risk factor for COPD & lung cancer.

 Ask about all forms of tobacco use (cigarettes, cigars, pipes, chewing tobacco, e-cigs, hookah).

 Assess exposure to secondhand smoke.

 Explore quit attempts and methods used.

 Document smoking history in pack-years.

 Ask about places lived/traveled → TB risk (immigration, prisons, shelters, HIV, IV drug use).

 Risk factors for fungal infections: soil, bird/rodent feces, polluted water, immunocompromised.

 Effect on family, work, and social life.

 Impact of meds, O₂ therapy, special routines (e.g., cystic fibrosis pulmonary hygiene).

 Occupational exposures: fumes, toxins, asbestos, coal, silica.

 Hobbies: woodworking, pottery, animal exposure → triggers.

 Asthma: hyperreactive airways triggered by smoke/fumes/chemicals.

11. Sexuality–Reproductive Pattern

 Breathing difficulties may affect intimacy.

 Discuss positions/strategies to reduce dyspnea.

 Encourage pulmonary hygiene before sexual activity.

 May need O₂ therapy during intercourse.

12. Coping–Stress Tolerance Pattern

 Dyspnea ↔ anxiety = vicious cycle, leads to deconditioning & isolation.

 Assess frequency of leaving home and social activity.

 Pulmonary rehab/support groups may help.

 Chronic illness = prolonged stress → assess coping strategies.

B. Objective Data Nose

 Inspect for patency, inflammation, deformities, symmetry, discharge.

 Test airflow by occluding each nostril.

 With speculum/light:

o Mucosa → pink, moist, no edema/exudate/bleeding.

o Septum → check deviation, perforation, bleeding (mild deviation = normal).

o Turbinates → inspect for polyps (from chronic irritation/allergies).

 Discharge:

o Purulent/malodorous = foreign body.

o Watery = allergies or CSF leak.

o Bloody = trauma/dryness.

o Thick = infection.

Mouth & Pharynx

 Inspect oral mucosa: color, lesions, masses, gums, dentition.

 Tongue → symmetry, lesions.

 Pharynx → smooth, moist, no exudate, ulcerations, swelling, or postnasal drip.

 Tonsils → assess color, symmetry, enlargement.

 Gag reflex → test CN IX (glossopharyngeal) & CN X (vagus).

Neck

 Inspect symmetry, swelling, tenderness.

 Palpate lymph nodes systematically (ears → skull base → mandible → midline).

 Normal: small, mobile, nontender (“shotty nodes”).

 Abnormal: tender, hard, fixed nodes.

Manifestations of Inadequate Oxygenation System Early Late Cardiovascu lar Dysrhythmias, mild HTN, tachycardia Dysrhythmias, hypotension, cyanosis, cool/clammy skin CNS Restlessness, irritability, apprehension, confusion/lethargy Confusion/lethargy, combativeness, coma Respiratory Dyspnea on exertion, tachypnea Dyspnea at rest, pauses between words, accessory muscle use, retractions Other Diaphoresis, fatigue, ↓ urine output Same as early (progresses) Thorax & Lungs General Exam Setup

 Use warm, well-lit room, ensure privacy.

 Expose chest; start with posterior chest (less interference from breast tissue).

 Posterior exam: patient leans forward, arms folded.

 Anterior exam: upright or semi-Fowler’s (30°); may lean forward for support.

Inspection

 Look for signs of distress: tachypnea, accessory muscle use.

 Chest shape/symmetry:

o Normal AP:transverse ratio = 1:2.

o Barrel chest = aging or hyperinflation.

o Sternum abnormalities: pectus carinatum (protrusion), pectus excavatum

(indentation).

o Spinal curvatures affecting breathing: kyphosis, scoliosis, kyphoscoliosis.

o Bronchovesicular : medium pitch, I:E = 1:1, heard between scapulae & 1st/2nd ICS

anteriorly.

o Vesicular : soft, low-pitched, rustling, I:E = 3:1, heard over most lung fields.

10. Normal vs. Abnormal Findings Normal

 Clear vesicular sounds, equal expansion, no accessory muscle use

Abnormal

 Crackles

o Fine: short, high-pitched, just before end of inspiration (atelectasis, early HF,

pulmonary fibrosis, pneumonia, edema).

o Coarse: loud, low-pitched, bubbling/snoring, inspiration &/or expiration

(pneumonia, pulmonary edema, COPD, HF).

 Wheezes: continuous high-pitched musical, mainly on expiration (asthma, COPD,

obstruction).

 Stridor: loud, crowing sound (croup, epiglottitis, foreign body, post-extubation

edema).

 Pleural friction rub: grating, creaking, both inspiration & expiration, no change with

cough (pleurisy, pneumonia, infarct).

 Absent breath sounds: pneumothorax, pleural effusion, obstruction, large

atelectasis, pneumonectomy.

 Voice changes:

o Bronchophony/whispered pectoriloquy: clearer words (pneumonia).

o Egophony: “E” sounds like “A” (pneumonia, effusion).

Inspection

 Abdominal paradox: inward abdomen on inspiration → severe distress.

 Accessory muscle use/retractions: COPD, asthma, secretion retention; severe

distress/hypoxemia.

 ↑ AP diameter (barrel chest): COPD, asthma, CF, hyperinflation, aging.

 Clubbing: bulbous fingertips → chronic hypoxemia, lung cancer, CF, bronchiectasis.

 Cyanosis: late hypoxemia; bluish lips, conjunctiva.

 Kussmaul respirations: rapid, deep, fruity odor → metabolic acidosis.

 Pursed-lip breathing: COPD/asthma; helps slow exhalation.

 Splinting: ↓ tidal volume due to pain (surgery, trauma, pleurisy).

 Tachypnea (>20/min): fever, anxiety, hypoxemia, restrictive disease.

 Tripod position: leaning forward with arms supported → COPD, asthma, pulmonary

edema, severe distress. Asthma Exacerbation

 Inspection: Prolonged expiration, tripod position, pursed-lip breathing.

 Palpation: ↓ chest movement.

 Percussion: Hyperresonant.

 Auscultation: Wheezes; ↓ breath sounds (ominous if very diminished).

Atelectasis

 Inspection: Usually no change unless large area involved.

 Palpation:

o Small: no change.

o Large: ↓ movement, ↓ fremitus.

 Percussion: Dull over affected area.

 Auscultation: Fine crackles (may clear with deep breaths); absent if large.

COPD

 Inspection: Barrel chest, cyanosis, tripod position, accessory muscle use.

 Palpation: ↓ movement.

 Percussion: Hyperresonant; dull if consolidation present.

 Auscultation: Crackles, wheezes, distant (quiet) breath sounds.

Pleural Effusion

 Inspection: Tachypnea, accessory muscle use.

 Palpation:

o ↑ movement/fremitus above effusion.

o Absent fremitus over effusion.

 Percussion: Dull.

 Auscultation: ↓ or absent breath sounds over effusion; egophony above effusion.

Pneumonia

 Inspection: Tachypnea, accessory muscle use, cyanosis/duskiness.

After VATS: Chest tube management, monitor breath sounds, encourage deep breathing. Mediastinoscopy

 Before: Consent, prep for OR and general anesthesia.

 After: Monitor as for bronchoscopy.

Exercise & Pulmonary Testing Exercise Testing

 Before: Ensure patient wears comfortable shoes.

 During: Encourage holding handlebars, walk as quickly as possible.

Pulmonary Function Tests (PFTs)

 Before: Avoid mealtime, no bronchodilators for 6 hr, assess for distress.

 During: Assess for distress.

 After: Monitor distress, provide rest.

Radiology Chest X-ray

 Before: Undress to waist, gown, remove metal objects.

CT Scan

 Before: Check renal function & shellfish/iodine allergy, NPO 4 hr if contrast used.

 During: Warn about flushed/warm feeling, patient must remain still.

 After: Encourage fluids to prevent renal issues.

MRI

 Before: Check pregnancy, allergies, renal function. Remove metal objects/patches, assess for

implanted devices or staples, claustrophobia (offer antianxiety meds). May need fasting.

 During: Remain still.

PET Scan

 Before: Obtain IV access, NPO 4 hr (except water/meds), hold glucose IV, check glucose (60–

140 mg/dL).

 During: Remain still.

 After: Encourage fluids to excrete tracer.

Pulmonary Angiogram

 Before: Assess contrast allergy, NPO 6–12 hr, give sedative.

 After: Monitor site (pressure dressing), BP, pulse, distal circulation, use compression device,

encourage fluids. Ventilation–Perfusion (V/Q) Scan

 Same as chest x-ray prep.

 After: No special precautions (radioactivity dissipates quickly).

6-Minute Walk Test

 During: Monitor SpO₂ and tolerance; allow rests as needed.

Thoracentesis

 Before: Explain procedure, obtain consent.

 During: Position upright leaning on overbed table, feet supported, instruct not to talk/cough.

 After: Monitor for hypoxia, pneumothorax, check breath sounds, encourage deep breaths, send

specimens promptly.